New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY
Springer US
1989, 1989
|
| Edition: | 1st ed. 1989 |
| Series: | Advances in Experimental Medicine and Biology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- I New Perspectives in Hemodialysis
- Protein catabolic factors in patients on renal replacement therapy
- ?2 Microglobulin-derived amyloid in dialysis patients
- Mechanisms and consequences of complement activation during hemodialysis
- Neutrophil activation during hemodialysis
- Biocompatibility — a system approach
- Treatment of uremic anaemia with recombinant human erythropoietin
- Endocrine abnormalities in patients with endstage renal failure
- Carnitine supplementation in uremia
- II Pharmacological Therapy in Dialyzed Patients
- Pathophysiology and treatment of hypertension in dialysis patients
- Adjustment of drug dosage to hemodialysis patients
- Pharmacokinetic aspects of drug transport in continuous ambulatory peritoneal dialysis
- Drug therapy during continuous arteriovenous hemofiltration
- III New Perspectives in Peritoneal Dialysis
- The biology of the peritoneal membrane during chronic peritoneal dialysis
- Lymphatic absorption during peritoneal dialysis
- CAPD with bicarbonate solution
- Glucose polymer as an osmotic agent in CAPD
- Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD
- IV New Perspectives in Hemofiltration and Plasmapheresis
- Continuous arterio-venous hemofiltration: Optimization of technical procedures and new directions
- Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment?
- Therapeutic apheresis update
- Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus